Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep

In 2012, Reuters published a piece that touched on the hesitancy that some doctors felt about a new generation of blood thinners, one of which was Xarelto. In 2011, the FDA had approved Xarelto for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgeries. A few months later, in

Bayer, the manufacturer of the blockbuster anticoagulant drug, Xarelto, is not only facing a significant number of lawsuits within the United States, but also abroad in other countries. Recently, a number of Canadian citizens have filed claims against Bayer, either on their own behalf or that of deceased family members. According to Toronto lawyer Bryan

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage

In the March issue of the medical journal Academic Emergency Medicine, researchers from around the world found a disturbing correlation between the incidence of Xarelto-related bleeding in patients who are already at a higher risk for pulmonary embolism (PE). The study, sponsored by the manufacturers of Xarelto, Bayer HealthCare and Janssen, included about 5,000

Last month, it was made known that Bayer and Johnson & Johnson, the companies responsible for manufacturing the blood thinner Xarelto, are pushing for additional FDA approvals for their drug. Xarelto is already being prescribed to patients to treat blood clots, such as deep-vein thrombosis (DVT) and pulmonary embolus (PE), that occur more frequently in

A freak accident occurred this Tuesday morning in New York City that left one female pedestrian severely injured. A massive construction-saw blade came loose at a construction site located in Hell’s Kitchen near Ninth Avenue and West 48th Street, and sliced the woman’s leg. According to witnesses, the saw disk disconnected from the machine at